Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transfer
Open Access
- 17 April 2010
- journal article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 17 (1) , 26
Abstract
Enzyme replacement therapy (ERT) with α-galactosidase A (α-Gal A) is currently the most effective therapeutic strategy for patients with Fabry disease, a lysosomal storage disease. However, ERT has limitations of a short half-life, requirement for frequent administration, and limited efficacy for patients with renal failure. Therefore, we investigated the efficacy of recombinant adeno-associated virus (rAAV) vector-mediated gene therapy for a Fabry disease mouse model and compared it with that of ERT.Keywords
This publication has 36 references indexed in Scilit:
- Large-Scale Adeno-Associated Viral Vector Production Using a Herpesvirus-Based System Enables Manufacturing for Clinical StudiesHuman Gene Therapy, 2009
- Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry diseaseBiologics: Targets and Therapy, 2008
- Gene Therapy Using Adeno-Associated Virus VectorsClinical Microbiology Reviews, 2008
- Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adultsNature Clinical Practice Nephrology, 2008
- Distribution of α-Galactosidase A in Normal Human Kidney and Renal Accumulation and Distribution of Recombinant α-Galactosidase A in Fabry MiceJournal of the American Society of Nephrology, 2007
- Biology of AAV Serotype Vectors in Liver-Directed Gene Transfer to Nonhuman PrimatesMolecular Therapy, 2006
- Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in MiceJournal of Virology, 2005
- Fabry disease in childhoodThe Journal of Pediatrics, 2004
- Immunohistochemical characterization of transgenic mice highly expressing human lysosomal α-galactosidaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1998
- Fabry disease: Immunocytochemical characterization of neuronal involvementAnnals of Neurology, 1992